Abstract
Proglumide, a cholecystokinin antagonist, did not improve Parkinson's disease in a preliminary drug treatment trial.
Publication types
-
Clinical Trial
-
Comparative Study
MeSH terms
-
Aged
-
Cholecystokinin / antagonists & inhibitors
-
Double-Blind Method
-
Drug Therapy, Combination
-
Female
-
Humans
-
Levodopa / therapeutic use
-
Male
-
Middle Aged
-
Parkinson Disease / drug therapy*
-
Proglumide / therapeutic use*
Substances
-
Levodopa
-
Cholecystokinin
-
Proglumide